🔎 Trials Near Me

Почетна › Рак дојке › Kalifornija

Kliničke studije za Рак дојке u državi Kalifornija

180 studija za Рак дојке traži učesnike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Zvanični tekst studije (na engleskom)

A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes

  • Community Cancer Institute (CCI), Clovis
  • The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente, Torrance
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07748208

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  • Providence Medical Foundation - Santa Rosa, CA, Santa Rosa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT05696626

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

  • Disney Family Cancer Center, Burbank
  • City of Hope, Corona
  • City of Hope Comprehensive Cancer Center, Duarte
  • и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT05894239

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

  • UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06797635

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

  • Glendale Adventist Medical Center d/b/a Adventist Health Glendale, Glendale
Тражи се учесник
Узраст 70 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07629206

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

  • Community Cancer Institute (CCI), Clovis
  • Orange Coast Medical Center, Fountain Valley
  • Stockton Hematology Oncology Medical Group-2626 N California St, Stockton
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 12. 11. 2026. · NCT07541079

BostonGene and Exigent Genomic INsight Study

  • Stockton Hematology Oncology Medical Group, Stockton
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06272864

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • City of Hope Comprehensive Cancer Center, Duarte
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • Contra Costa Regional Medical Center, Martinez
  • и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03418961

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

  • Keck Medicine of USC Koreatown, Los Angeles
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • и још 1
Тражи се учесникФаза 1
Узраст 12 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05372640

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

  • Research Facility, Irvine
  • Research Facility, San Diego
  • Research Facility, Santa Monica
Тражи се учесникФаза 1/2
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT06590857

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

  • Beverly Hills Cancer Center, Beverly Hills
  • Hoag Memorial Hospital Presbyterian, Newport Beach
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06827236

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Roy and Patricia Disney Family Cancer Center ( Site 0055), Burbank
  • Community Cancer Institute ( Site 0100), Clovis
  • Providence Medical Foundation ( Site 0080), Fullerton
  • и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06966700

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

  • Ellison Institute, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT04557449

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

  • City of Hope Medical Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06260033

Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer

  • City of Hope Medical Center, Duarte
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07664579

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • City of Hope, Duarte
  • UC San Diego Moores Cancer Center, La Jolla
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07007559

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

  • City of Hope - Duarte, Duarte
  • City of Hope - Orange County Lennar Foundation Cancer Center, Irvine
  • University of California San Diego (UCSD) - Koman Family Outpatient Pavilion ? La Jolla, La Jolla
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT03424005

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Kaiser Permanente-Division of Research, Pleasanton
  • Naval Medical Center -San Diego, San Diego
Тражи се учесникЗдраве особе су добродошле
Узраст од 45 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06995898

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

  • University of California, San Diego, San Diego
  • University of California, San Francisco, San Francisco
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT05964504

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • City of Hope, Duarte
  • UC San Diego Moores Cancer Center, La Jolla
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07029399

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • The Oncology Institute of Hope and Innovation, Cerritos
  • Ellison Medical Institute, Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
  • и још 3
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06324357

INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study

  • University of California Los Angeles (UCLA), Los Angeles
Тражи се учесникНаводи исплату за учеснике
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07671937

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07318805

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

  • Marin Cancer Care, Greenbrae
  • Loma Linda University, Loma Linda
  • Cancer and Blood Research Center, Los Alamitos
  • и још 3
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07214532

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

  • City of Hope, Duarte
  • City of Hope, Huntington Beach
  • City of Hope, Irvine
  • и још 2
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT05315700

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • Beverly Hills Cancer Center, Beverly Hills
  • City of Hope National Medical Center, Duarte
  • Cedars-Sinai Medical Center, Los Angeles
  • и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06982521

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Community Cancer Institute, Clovis
  • City of Hope, Duarte
  • Epic Care - Emeryville, Emeryville
  • и још 17
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

  • Disney Family Cancer Center, Burbank
  • City of Hope - Lennar Foundation Cancer Center, Irvine
  • Scripps Health, La Jolla
  • и још 7
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06790693

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • City of Hope, Duarte
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 40 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05366881

E-Mindfulness Approaches for Living After Breast Cancer

  • Kaiser Permanente-Anaheim, Anaheim
  • Kaiser Permanente-Deer Valley Medical Center, Antioch
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • и још 56
Тражи се учесникФаза 3
Узраст од 18 до 50 · Оба пола · Ажурирано 4. 11. 2026. · NCT06748222

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

  • City of Hope, Duarte
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 4. 11. 2026. · NCT07287098

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • и још 22
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • University of California Los Angeles Medical Center, Los Angeles
  • University of California, San Diego; Moores Cancer Center, San Diego
  • USOR Sansum Clinic, Santa Barbara
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05579366

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Kaiser Permanente-Deer Valley Medical Center, Antioch
  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • и још 39
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06400472

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford University Medical Center, Stanford
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213791

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • City of Hope, Duarte
  • University of California, Los Angeles (UCLA), Santa Monica
  • Stanford University Medical Center, Stanford
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07114601

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • и још 10
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07059884

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • City of Hope - Duarte Cancer Center, Duarte
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06760819

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Kaiser Permanente-Anaheim, Anaheim
  • Kaiser Permanente-Deer Valley Medical Center, Antioch
  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • и још 107
Тражи се учесникФаза 3
Узраст од 18 до 60 · Жене · Ажурирано 4. 11. 2026. · NCT05879926

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.